These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3884063)

  • 1. Utilization of a colony assay to assess the variables influencing elimination of leukemic cells from human bone marrow with monoclonal antibodies and complement.
    LeBien TW; Stepan DE; Bartholomew RM; Stong RC; Anderson JM
    Blood; 1985 Apr; 65(4):945-50. PubMed ID: 3884063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective cytotoxicity of murine monoclonal antibody LAM2 against human small-cell carcinoma in the presence of human complement: possible use for in vitro elimination of tumor cells from bone marrow.
    Stahel RA; Mabry M; Sabbath K; Speak JA; Bernal SD
    Int J Cancer; 1985 May; 35(5):587-92. PubMed ID: 2987136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased efficacy in selective elimination of leukemic cell line clonogenic cells by a combination of monoclonal antibodies BA-1, BA-2, BA-3 + complement and mafosfamid (ASTA Z 7557).
    LeBien TW; Anderson JM; Vallera DA; Uckun FM
    Leuk Res; 1986; 10(2):139-43. PubMed ID: 3951251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody:ricin A chain conjugates.
    Bregni M; De Fabritiis P; Raso V; Greenberger J; Lipton J; Nadler L; Rothstein L; Ritz J; Bast RC
    Cancer Res; 1986 Mar; 46(3):1208-13. PubMed ID: 3510720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous bone marrow transplantation in high-risk remission B-lineage acute lymphoblastic leukemia using a cocktail of three monoclonal antibodies (BA-1/CD24, BA-2/CD9, and BA-3/CD10) plus complement and 4-hydroperoxycyclophosphamide for ex vivo bone marrow purging.
    Uckun FM; Kersey JH; Haake R; Weisdorf D; Ramsay NK
    Blood; 1992 Feb; 79(4):1094-104. PubMed ID: 1531306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective purging of bone marrow by a combination of immunorosette depletion and complement lysis.
    Slaper-Cortenbach IC; Admiraal LG; van Leeuwen EF; Kerr JM; von dem Borne AE; Tetteroo PA
    Exp Hematol; 1990 Jan; 18(1):49-54. PubMed ID: 2298269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elimination of leukemic cells from human bone marrow using monoclonal antibody and complement.
    Bast RC; Ritz J; Lipton JM; Feeney M; Sallan SE; Nathan DG; Schlossman SF
    Cancer Res; 1983 Mar; 43(3):1389-94. PubMed ID: 6337707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous bone marrow transplantation in acute myelogenous leukemia: in vitro treatment with myeloid-specific monoclonal antibodies and drugs in combination.
    Lemoli RM; Gasparetto C; Scheinberg DA; Moore MA; Clarkson BD; Gulati SC
    Blood; 1991 Apr; 77(8):1829-36. PubMed ID: 2015406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the individual and combined reactivities of monoclonal antibodies H25, H366, and MY9 with normal progenitor cells and blast cells from patients with acute myeloblastic leukemia.
    Wisniewski D; Strife A; Arlin Z; Knowles R; Lambek C; Gulati S; McHendry B; McKenzie S; Clarkson B
    Leukemia; 1989 Jun; 3(6):446-52. PubMed ID: 2657231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lysis of leukemia cells with a monoclonal antibody-cocktail (e.g. VIP-pool) and human complement].
    Reiners B; Thränhardt H; Häfer R; Zintl F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(1):84-96. PubMed ID: 2439421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a novel colony assay to evaluate the cytotoxicity of an immunotoxin containing pokeweed antiviral protein against blast progenitor cells freshly obtained from patients with common B-lineage acute lymphoblastic leukemia.
    Uckun FM; Gajl-Peczalska KJ; Kersey JH; Houston LL; Vallera DA
    J Exp Med; 1986 Feb; 163(2):347-68. PubMed ID: 3511171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of a cocktail of monoclonal antibodies and human complement in selective killing of acute lymphocytic leukemia cells.
    Sugita K; Majdic O; Stockinger H; Holter W; Köller U; Peschel C; Knapp W
    Int J Cancer; 1986 Mar; 37(3):351-7. PubMed ID: 3456339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-clinical evaluation of anti-lacto-N-fucopentaose III (CD15) monoclonal antibodies for ex vivo bone marrow purging in acute myeloid leukemia.
    Guyotat D; Shi ZH; Campos L; Rabat M; Bonnier S; Poncelet P; Laurent JC; Fiere D
    Bone Marrow Transplant; 1990 Dec; 6(6):385-90. PubMed ID: 1982926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Removal of neoplastic cells from autologous bone marrow grafts with monoclonal antibodies.
    Jansen J; Falkenburg JH; Stepan DE; LeBien TW
    Semin Hematol; 1984 Jul; 21(3):164-81. PubMed ID: 6379879
    [No Abstract]   [Full Text] [Related]  

  • 15. Elimination of clonogenic Burkitt's lymphoma cells from human bone marrow using 4-hydroperoxycyclophosphamide in combination with monoclonal antibodies and complement.
    De Fabritiis P; Bregni M; Lipton J; Greenberger J; Nadler L; Rothstein L; Korbling M; Ritz J; Bast RC
    Blood; 1985 May; 65(5):1064-70. PubMed ID: 3995166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elimination of drug-resistant myeloma tumor cell lines by monoclonal anti-P-glycoprotein antibody and rabbit complement.
    Kulkarni SS; Wang ZM; Spitzer G; Taha M; Hamada H; Tsuruo T; Dicke KA
    Blood; 1989 Nov; 74(6):2244-51. PubMed ID: 2572283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elimination of malignant clonogenic cells from human bone marrow using multiple monoclonal antibodies and complement.
    Bast RC; De Fabritiis P; Lipton J; Gelber R; Maver C; Nadler L; Sallan S; Ritz J
    Cancer Res; 1985 Feb; 45(2):499-503. PubMed ID: 3967224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro treatment of human acute lymphocytic leukemia cells in bone marrow with a cocktail of monoclonal antibodies.
    Nakamura H; Hirayama F; Tatsumi Y; Tani Y; Kubota Y; Kanakura Y; Oguma S; Ueda T; Shibata H; Masaoka T
    Jpn J Clin Oncol; 1984 Dec; 14 Suppl 1():537-42. PubMed ID: 6596454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological and pharmacological removal of small cell lung cancer cells from bone marrow autografts.
    Humblet Y; Feyens AM; Sekhavat M; Agaliotis D; Canon JL; Symann ML
    Cancer Res; 1989 Sep; 49(18):5058-61. PubMed ID: 2548708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro cytodestruction of human leukemic cells using murine monoclonal antibodies and human complement.
    Stepan DE; Bartholomew RM; LeBien TW
    Blood; 1984 May; 63(5):1120-4. PubMed ID: 6585233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.